EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells

Isaac Zin iD, Arnab China, Krishnendu Khan, Jeetendra K Nag iD, Kommireddy Vasu, Gauravi M Deshpande iD, Prabar K Ghosh, Debjit Khan, Iyappan Ramachandiran, Shinjini Ganguly iD, Ilaria Tamagno, Belinda Willard iD und 2 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2303642121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Isaac Zin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195. Hauptthemen laut MEDLINE: Breast Neoplasms, Poly (ADP-Ribose) Polymerase-1, Cell Nucleus, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutamyl-prolyl-tRNA synthetase (EPRS1) is a bifunctional aminoacyl-tRNA-synthetase (aaRS) essential for decoding the genetic code. EPRS1 resides, with seven other aaRSs and three noncatalytic proteins, in the cytoplasmic multi-tRNA synthetase complex (MSC). Multiple MSC-resident aaRSs, including EPRS1, exhibit stimulus-dependent release from the MSC to perform noncanonical activities distinct from their primary function in protein synthesis. Here, we show EPRS1 is present in both cytoplasm and nucleus of breast cancer cells with constitutively low phosphatase and tensin homolog (PTEN) expression. EPRS1 is primarily cytosolic in PTEN-expressing cells, but chemical or genetic inhibition of PTEN, or chemical or stress-mediated activation of its target, AKT, induces EPRS1 nuclear localization. Likewise, preferential nuclear localization of EPRS1 was observed in invasive ductal carcinoma that were also P-Ser 473 -AKT + . EPRS1 nuclear transport requires a nuclear localization signal (NLS) within the linker region that joins the catalytic glutamyl-tRNA synthetase and prolyl-tRNA synthetase domains. Nuclear EPRS1 interacts with poly(ADP-ribose) polymerase 1 (PARP1), a DNA-damage sensor that directs poly(ADP-ribosyl)ation (PARylation) of proteins. EPRS1 is a critical regulator of PARP1 activity as shown by markedly reduced ADP-ribosylation in EPRS1 knockdown cells. Moreover, EPRS1 and PARP1 knockdown comparably alter the expression of multiple tumor-related genes, inhibit DNA-damage repair, reduce tumor cell survival, and diminish tumor sphere formation by breast cancer cells. EPRS1-mediated regulation of PARP1 activity provides a mechanistic link between PTEN loss in breast cancer cells, PARP1 activation, and cell survival and tumor growth. Targeting the noncanonical activity of EPRS1, without inhibiting canonical tRNA ligase activity, provides a therapeutic approach potentially supplementing existing PARP1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPoly (ADP-Ribose) Polymerase-1Cell NucleusProto-Oncogene Proteins c-aktHumansFemaleCell Line, TumorPTEN PhosphohydrolaseAmino Acyl-tRNA SynthetasesActive Transport, Cell NucleusNuclear Localization Signals

Stichwörter der Autor:innen

ADP-ribosylationAKTEPRS1PARP1aminoacyl-tRNA synthetase

Substanzen

Poly (ADP-Ribose) Polymerase-1Proto-Oncogene Proteins c-aktPARP1 protein, humanPTEN PhosphohydrolaseAmino Acyl-tRNA SynthetasesPTEN protein, humanNuclear Localization Signals

Autor:innen und Institutionen

  • Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Department of Chemistry, Cleveland State University, Cleveland, OH 44115.
  • Imaging Core, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Proteomics and Metabolomics Core, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.

ORCID-Profile: Isaac Zin, Jeetendra K Nag, Gauravi M Deshpande, Shinjini Ganguly, Belinda Willard, Valentin Gogonea, Paul L Fox

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • NIDDK NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
  • HHS | NIH | National Institute on Aging
  • HHS | NIH | National Institute of Neurological Disorders and Stroke

Zitieren

APA

Zin, I., China, A., Khan, K., Nag, J. K., Vasu, K., Deshpande, G. M., Ghosh, P. K., Khan, D., Ramachandiran, I., Ganguly, S., Tamagno, I., Willard, B., Gogonea, V., & Fox, P. L. (2024). AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2303642121

Vancouver

Zin I, China A, Khan K, Nag JK, Vasu K, Deshpande GM, et al. AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2303642121

BibTeX
@article{Zin2024,
  author = {Zin, Isaac and China, Arnab and Khan, Krishnendu and Nag, Jeetendra K and Vasu, Kommireddy and Deshpande, Gauravi M and Ghosh, Prabar K and Khan, Debjit and Ramachandiran, Iyappan and Ganguly, Shinjini and Tamagno, Ilaria and Willard, Belinda and Gogonea, Valentin and Fox, Paul L},
  title = {AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2303642121}
}
Kostenlos starten →